Published in Blood Weekly, February 25th, 2010
"Flow cytometry was performed to characterize cell cycle profile in response to berbamine treatment. Western blot was used to measure the protein levels of p65, I kappa B Kinase alpha (IKK alpha), TNFAIP3 (A20), I kappa B alpha, p-I kappa B alpha, cyclinD1, Bcl-2, BAX, Bcl-x(L), Bid, and survivin. Berbamine inhibits the proliferation of KM3...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.